By Editor • August 28, 2026 • 1 min read
NHS leaders are sounding the alarm over skyrocketing costs for ADHD and autism services in England, with spending surging tenfold in some regions within a year.
The NHS Alliance reports that increased demand post-pandemic is straining resources, leading to closed waiting lists and potential cuts to other services.
Source: www.theguardian.com
By Editor • August 28, 2026 • 1 min read
Autism advocates are alarmed by RFK Jr.'s research plan, which may divert funds from crucial genetic studies to unreliable therapies.
Read moreBy Editor • August 28, 2026 • 1 min read
Cytokinetics reveals positive data for aficamten, targeting nHCM, and plans FDA submission by year-end for potential approval.
Read moreBy Editor • August 28, 2026 • 1 min read
AstraZeneca's heart disease drug trial failed to show benefits for patients already on stabilizers, impacting the broader ATTR-CM market.
Read more
